Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Hoepelman

Showing results (11-20 of 334) with videos related to

Pageof 34
Sort By:
Annali Dell'Istituto Superiore Di Sanita|January 1, 1987
Antimicrobial agents and opsonic defenceI M Hoepelman, J Verhoef
Nederlands Tijdschrift Voor Geneeskunde|January 25, 1986
[Anemia caused by participation in sports; an innocent 'side effect' of a healthy hobby]I M Hoepelman, J J Marx
Clinical Pharmacokinetics|December 1, 1993
Aminoglycoside dosage regimens. Is once a day enough?W N Hustinx, I M Hoepelman
Nederlands Tijdschrift Voor Geneeskunde|June 26, 2003
[Splenectomy and pneumococcal vaccination]I M Hoepelman, T F Wolfs
International Journal of Antimicrobial Agents|May 1, 1995
Azithromycin: the first of the tissue-selective azalidesI M Hoepelman, M M Schneider
Nederlands Tijdschrift Voor Geneeskunde|August 18, 1990
[When and how should primary prevention against Pneumocystis carinii pneumonia be carried out in HIV infection?]J K Eeftinck Schattenkerk, I M Hoepelman
European Journal of Clinical Investigation|June 1, 2020
An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publicationJesper M Weehuizen, Andy I M Hoepelman
Nederlands Tijdschrift Voor Geneeskunde|October 12, 2001
[Candidate vaccine against urinary tract infections]I M Hoepelman, R Meiland, S Langermann
Nederlands Tijdschrift Voor Geneeskunde|September 25, 2014
[Middle-East respiratory syndrome]Jan Jelrik Oosterheert, Andy I M Hoepelman
Lancet (London, England)|June 11, 1988
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infectionsI M Hoepelman, M Rozenberg-Arska, J Verhoef
Pageof 34

Showing results (11-20 of 334) with videos related to

Sort By:
Pageof 34
Annali Dell'Istituto Superiore Di Sanita|January 1, 1987
Antimicrobial agents and opsonic defenceI M Hoepelman, J Verhoef
Nederlands Tijdschrift Voor Geneeskunde|January 25, 1986
[Anemia caused by participation in sports; an innocent 'side effect' of a healthy hobby]I M Hoepelman, J J Marx
Clinical Pharmacokinetics|December 1, 1993
Aminoglycoside dosage regimens. Is once a day enough?W N Hustinx, I M Hoepelman
Nederlands Tijdschrift Voor Geneeskunde|June 26, 2003
[Splenectomy and pneumococcal vaccination]I M Hoepelman, T F Wolfs
International Journal of Antimicrobial Agents|May 1, 1995
Azithromycin: the first of the tissue-selective azalidesI M Hoepelman, M M Schneider
Nederlands Tijdschrift Voor Geneeskunde|August 18, 1990
[When and how should primary prevention against Pneumocystis carinii pneumonia be carried out in HIV infection?]J K Eeftinck Schattenkerk, I M Hoepelman
European Journal of Clinical Investigation|June 1, 2020
An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publicationJesper M Weehuizen, Andy I M Hoepelman
Nederlands Tijdschrift Voor Geneeskunde|October 12, 2001
[Candidate vaccine against urinary tract infections]I M Hoepelman, R Meiland, S Langermann
Nederlands Tijdschrift Voor Geneeskunde|September 25, 2014
[Middle-East respiratory syndrome]Jan Jelrik Oosterheert, Andy I M Hoepelman
Lancet (London, England)|June 11, 1988
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infectionsI M Hoepelman, M Rozenberg-Arska, J Verhoef
Pageof 34